Claire Henchcliffe

Title(s)Clinical Professor, Neurology
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-7352
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Neurologic and psychiatric features of impending neurodegeneration in iRBD. Clin Park Relat Disord. 2023; 9:100216. Barone DA, Sarva H, Hellmers N, Wang F, Wu Z, Krieger AC, Henchcliffe C. PMID: 37680305; PMCID: PMC10480303.
      View in: PubMed   Mentions:
    2. Clinical Review of Smartphone Applications in Parkinson's Disease. Neurologist. 2022 Jul 01; 27(4):183-193. Tripathi S, Malhotra A, Qazi M, Chou J, Wang F, Barkan S, Hellmers N, Henchcliffe C, Sarva H. PMID: 35051970.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy. Orphanet J Rare Dis. 2022 01 29; 17(1):23. Korb M, Peck A, Alfano LN, Berger KI, James MK, Ghoshal N, Healzer E, Henchcliffe C, Khan S, Mammen PPA, Patel S, Pfeffer G, Ralston SH, Roy B, Seeley WW, Swenson A, Mozaffar T, Weihl C, Kimonis V, VCP Standards of Care Working Group. PMID: 35093159; PMCID: PMC8800193.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    4. Contemporary Neuroscience Core Curriculum for Medical Schools. Neurology. 2021 Oct 04; 97(14):675-684. Gelb DJ, Kraakevik J, Safdieh JE, Agarwal S, Odia Y, Govindarajan R, Quick A, Soni M, and the AAN Undergraduate Education Subcommittee (UES), Bickel J, Gamaldo C, Hannon P, Hatch HAM, Hernandez C, Merlin LR, Noble JM, Reyes-Iglesias Y, Salas RME, Sandness DJ, Treat L, and the AAN Education Committee, Benameur K, Brown RD, DeLuca GC, Garg N, Goldstein LB, Gutmann L, Henchcliffe C, Hessler A, Jordan JT, Kilgore SM, Khan J, Levin KH, Mohile NA, Nevel KS, Roberts K, Said RR, Simpson EP, Sirven JI, Smith AG, Southerland AM, Wilson RB. PMID: 34400582; PMCID: PMC8520386.
      View in: PubMed   Mentions: 3     Fields:    
    5. Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data. NPJ Parkinsons Dis. 2021 Sep 17; 7(1):83. Brendel M, Su C, Hou Y, Henchcliffe C, Wang F. PMID: 34535682; PMCID: PMC8448859.
      View in: PubMed   Mentions: 4  
    6. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 09 14; 326(10):926-939. Parkinson Study Group SURE-PD3 Investigators, Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. PMID: 34519802; PMCID: PMC8441591.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    7. Comparison of the Parkinson's KinetiGraph to off/on levodopa response testing: Single center experience. Clin Neurol Neurosurg. 2021 10; 209:106890. Guan I, Trabilsy M, Barkan S, Malhotra A, Hou Y, Wang F, Hellmers N, Sarva H, Henchcliffe C. PMID: 34455169.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Characteristics and Outcomes of Parkinson's Disease Individuals Hospitalized with COVID-19 in a New York City Hospital System. Mov Disord Clin Pract. 2021 Oct; 8(7):1100-1106. Nwabuobi L, Zhang C, Henchcliffe C, Shah H, Sarva H, Lee A, Kamel H. PMID: 34541022; PMCID: PMC8441912.
      View in: PubMed   Mentions: 7  
    9. Baseline Differences in Long-term Survivors and Nonsurvivors of the Colorado/Columbia Fetal Implant Trial. J Int Neuropsychol Soc. 2022 05; 28(5):452-459. McRae C, Dunk M, Russell D, Ellgring H, Stern Y, Greene P, Fahn S, Henchcliffe C. PMID: 34121635.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Population-based input function for TSPO quantification and kinetic modeling with [11C]-DPA-713. EJNMMI Phys. 2021 Apr 29; 8(1):39. Akerele MI, Zein SA, Pandya S, Nikolopoulou A, Gauthier SA, Raj A, Henchcliffe C, Mozley PD, Karakatsanis NA, Gupta A, Babich J, Nehmeh SA. PMID: 33914185; PMCID: PMC8085191.
      View in: PubMed   Mentions: 3  
    11. Tablet-based patient educational interventions in care and management of complex movement disorders. Disabil Rehabil Assist Technol. 2023 07; 18(5):627-634. Hellmers N, Barkan S, Auerbach G, Hanineva A, Popa P, Sarva H, Henchcliffe C. PMID: 33784918.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01. Cell Stem Cell. 2021 02 04; 28(2):217-229.e7. Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, Rosen S, Ramnarine K, Horn C, Fredrickson C, Wong K, Safford B, Kriks S, El Maarouf A, Rutishauser U, Henchcliffe C, Wang Y, Riviere I, Mann S, Bermudez V, Irion S, Studer L, Tomishima M, Tabar V. PMID: 33545080; PMCID: PMC7903922.
      View in: PubMed   Mentions: 67     Fields:    Translation:AnimalsCells
    13. Can google glass™ technology improve freezing of gait in parkinsonism? A pilot study. Disabil Rehabil Assist Technol. 2023 04; 18(3):327-332. Lee A, Hellmers N, Vo M, Wang F, Popa P, Barkan S, Patel D, Campbell C, Henchcliffe C, Sarva H. PMID: 33216658.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    14. Toward a Personalized Approach to Parkinson's Cell Therapy. Mov Disord. 2020 11; 35(11):2119-2120. Herrington TM, Schweitzer J, Henchcliffe C, Carter BS, Kim KS. PMID: 33463754.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease. Front Neurosci. 2020; 14:528809. Ivanidze J, Skafida M, Pandya S, Patel D, Osborne JR, Raj A, Gupta A, Henchcliffe C, Dyke JP. PMID: 33071729; PMCID: PMC7530280.
      View in: PubMed   Mentions: 10  
    16. A machine learning and network framework to discover new indications for small molecules. PLoS Comput Biol. 2020 08; 16(8):e1008098. Gilvary C, Elkhader J, Madhukar N, Henchcliffe C, Goncalves MD, Elemento O. PMID: 32764756; PMCID: PMC7437923.
      View in: PubMed   Mentions: 4     Fields:    
    17. Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials. JAMA Neurol. 2020 06 01; 77(6):755-763. Cudkowicz M, Chase MK, Coffey CS, Ecklund DJ, Thornell BJ, Lungu C, Mahoney K, Gutmann L, Shefner JM, Staley KJ, Bosch M, Foster E, Long JD, Bayman EO, Torner J, Yankey J, Peters R, Huff T, Conwit RA, NeuroNEXT Clinical Study Sites, Shinnar S, Patch D, Darras BT, Ellis A, Packer RJ, Marder KS, Chiriboga CA, Henchcliffe C, Moran JA, Nikolov B, Factor SA, Seeley C, Greenberg SM, Amato AA, DeGregorio S, Simuni T, Ward T, Kissel JT, Kolb SJ, Bartlett A, Quinn JF, Keith K, Levine SR, Gilles N, Coyle PK, Lamb J, Wolfe GI, Crumlish A, Mejico L, Iqbal MM, Bowen JD, Tongco C, Nabors LB, Bashir K, Benge M, McDonald CM, Henricson EK, Oskarsson B, Dobkin BH, Canamar C, Glauser TA, Woo D, Molloy A, Clark P, Vollmer TL, Stein AJ, Barohn RJ, Dimachkie MM, Le Pichon JB, Benatar MG, Steele J, Wechsler L, Clemens PR, Amity C, Holloway RG, Annis C, Goldberg MP, Andersen M, Iannaccone ST, Smith AG, Singleton JR, Doudova M, Haley EC, Quigg MS, Lowenhaupt S, Malow BA, Adkins K, Clifford DB, Teshome MA, Connolly N. PMID: 32202612; PMCID: PMC7483960.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's Disease. CNS Drugs. 2020 06; 34(6):559-577. Henchcliffe C, Sarva H. PMID: 32472450.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    19. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. N Engl J Med. 2020 05 14; 382(20):1926-1932. Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS. PMID: 32402162; PMCID: PMC7288982.
      View in: PubMed   Mentions: 176     Fields:    Translation:HumansAnimalsCells
    20. Comorbid neuropsychiatric and autonomic features in REM sleep behavior disorder. Clin Park Relat Disord. 2020; 3:100044. Barone DA, Wang F, Ravdin L, Vo M, Lee A, Sarva H, Hellmers N, Krieger AC, Henchcliffe C. PMID: 34316629; PMCID: PMC8298794.
      View in: PubMed   Mentions: 3  
    21. The future of stem cell therapies for Parkinson disease. Nat Rev Neurosci. 2020 02; 21(2):103-115. Parmar M, Grealish S, Henchcliffe C. PMID: 31907406.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansAnimalsCells
    22. Neurophysiological Biomarkers of Parkinson's Disease. J Parkinsons Dis. 2020; 10(2):471-480. Waninger S, Berka C, Stevanovic Karic M, Korszen S, Mozley PD, Henchcliffe C, Kang Y, Hesterman J, Mangoubi T, Verma A. PMID: 32116262; PMCID: PMC7242849.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    23. Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks. Front Aging Neurosci. 2019; 11:315. Rahman A, Jackson H, Hristov H, Isaacson RS, Saif N, Shetty T, Etingin O, Henchcliffe C, Brinton RD, Mosconi L. PMID: 31803046; PMCID: PMC6872493.
      View in: PubMed   Mentions: 64  
    24. Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism Relat Disord. 2019 08; 65:178-183. Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, Kang UJ. PMID: 31255537; PMCID: PMC6774826.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    25. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study. Sci Rep. 2019 01 28; 9(1):797. Zhang X, Chou J, Liang J, Xiao C, Zhao Y, Sarva H, Henchcliffe C, Wang F. PMID: 30692568; PMCID: PMC6349906.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    26. 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease. J Neuroimaging. 2019 01; 29(1):97-103. Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, Mozley PD. PMID: 30230118.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    27. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies. Clin Neurophysiol. 2018 08; 129(8):1551-1564. Barone DA, Henchcliffe C. PMID: 29883833; PMCID: PMC6495539.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    28. Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease. J Neuroimaging. 2018 09; 28(5):496-505. Kang Y, Mozley PD, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J, Sullivan JM, Pryor KO, Hesterman J, Kothari PJ, Vallabhajosula S. PMID: 29727504; PMCID: PMC6174975.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    29. Valbenazine as the first and only approved treatment for adults with tardive dyskinesia. Expert Rev Clin Pharmacol. 2018 Mar; 11(3):209-217. Sarva H, Henchcliffe C. PMID: 29338466.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    30. Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies. J Parkinsons Dis. 2018; 8(s1):S131-S137. Henchcliffe C, Parmar M. PMID: 30584166; PMCID: PMC6311366.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    31. Kufor-Rakeb Syndrome Due to a Novel ATP13A2 Mutation in 2 Chinese-American Brothers. Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):92-95. Noch E, Henchcliffe C, Hellmers N, Chu ML, Pappas J, Moran E, Alcaraz W, Sarva H. PMID: 30746398; PMCID: PMC6336435.
      View in: PubMed   Mentions: 1  
    32. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Mov Disord. 2018 02; 33(2):282-288. Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K, Fox Investigation of New Biomarker Discovery, Kang UJ. PMID: 29205509; PMCID: PMC5836918.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    33. Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis. Ther Adv Neurol Disord. 2016 Nov; 9(6):462-473. Sarva H, Henchcliffe C. PMID: 27800022; PMCID: PMC5066530.
      View in: PubMed   Mentions: 1  
    34. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Mov Disord. 2016 06; 31(6):924-32. Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, Vincent L, Frasier M. PMID: 27113479; PMCID: PMC5021110.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    35. Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases. Neural Regen Res. 2016 Jan; 11(1):83-5. Hellmers N, Obeng-Aduasare Y, de Melo-Martín I, Henchcliffe C. PMID: 26981090; PMCID: PMC4774238.
      View in: PubMed   Mentions: 1  
    36. First-in-human cell transplant trials in Parkinson's disease: The need for an improved informed consent process. Parkinsonism Relat Disord. 2015 Aug; 21(8):829-32. de Melo-Martín I, Hellmers N, Henchcliffe C. PMID: 26004682.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson's disease (PD). J Neural Transm (Vienna). 2015 Sep; 122(9):1263-70. Westheimer O, McRae C, Henchcliffe C, Fesharaki A, Glazman S, Ene H, Bodis-Wollner I. PMID: 25836752.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    38. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014 May; 71(5):543-52. Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K. PMID: 24664227.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCTClinical Trials
    39. Sex differences in cerebral energy metabolism in Parkinson's disease: a phosphorus magnetic resonance spectroscopic imaging study. Parkinsonism Relat Disord. 2014 May; 20(5):545-8. Weiduschat N, Mao X, Beal MF, Nirenberg MJ, Shungu DC, Henchcliffe C. PMID: 24593902.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    40. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease. J Neuroimaging. 2015 Jan-Feb; 25(1):105-10. Weiduschat N, Mao X, Beal MF, Nirenberg MJ, Shungu DC, Henchcliffe C. PMID: 24325203.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    41. Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study. Dement Geriatr Cogn Disord. 2013; 35(3-4):183-96. Huang C, Ravdin LD, Nirenberg MJ, Piboolnurak P, Severt L, Maniscalco JS, Solnes L, Dorfman BJ, Henchcliffe C. PMID: 23445555.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    42. Biomarkers in Parkinson's disease: an update. Curr Opin Neurol. 2012 Aug; 25(4):460-5. Shtilbans A, Henchcliffe C. PMID: 22772875.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    43. Clinical characteristics of exacerbations in Parkinson disease. Neurologist. 2012 May; 18(3):120-4. Zheng KS, Dorfman BJ, Christos PJ, Khadem NR, Henchcliffe C, Piboolnurak P, Nirenberg MJ. PMID: 22549349; PMCID: PMC3626090.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    44. Biomarkers of Parkinson's disease and Dementia with Lewy bodies. Prog Neurobiol. 2011 Dec; 95(4):601-13. Henchcliffe C, Dodel R, Beal MF. PMID: 21983334.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    45. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain. 2011 Nov; 134(Pt 11):3146-66. Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. PMID: 21810889.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    46. Disease modification in Parkinson's disease. Drugs Aging. 2011 Aug 01; 28(8):605-15. Henchcliffe C, Severt WL. PMID: 21812497.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    47. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010 Dec 06; 4:1427-32. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. PMID: 21188154; PMCID: PMC3000768.
      View in: PubMed   Mentions: 47  
    48. Clinical predictors of frequent patient telephone calls in Parkinson's disease. Parkinsonism Relat Disord. 2011 Feb; 17(2):95-9. Liu AA, Boxhorn CE, Klufas MA, Christos PJ, Thorne JT, Shih AY, Tsankova NM, Dorfman BJ, Henchcliffe C, Piboolnurak P, Nirenberg MJ. PMID: 21112806; PMCID: PMC3612399.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    49. How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings. Eur J Neurol. 2010 Jun 01; 17(6):882-4. Louis ED, Rios E, Henchcliffe C. PMID: 20067514; PMCID: PMC2889923.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    50. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009; 5:597-610. Spindler M, Beal MF, Henchcliffe C. PMID: 19966907; PMCID: PMC2785862.
      View in: PubMed   Mentions: 72  
    51. Mirror movements in patients with essential tremor. Mov Disord. 2009 Nov 15; 24(15):2211-7. Louis ED, Rios E, Henchcliffe C. PMID: 19795466; PMCID: PMC2847261.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    52. Metabolomic profiling in LRRK2-related Parkinson's disease. PLoS One. 2009 Oct 22; 4(10):e7551. Johansen KK, Wang L, Aasly JO, White LR, Matson WR, Henchcliffe C, Beal MF, Bogdanov M. PMID: 19847307; PMCID: PMC2761616.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    53. Older onset essential tremor: More rapid progression and more degenerative pathology. Mov Disord. 2009 Aug 15; 24(11):1606-12. Louis ED, Faust PL, Vonsattel JP, Honig LS, Henchcliffe C, Pahwa R, Lyons KE, Rios E, Erickson-Davis C, Moskowitz CB, Lawton A. PMID: 19526587; PMCID: PMC2736358.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    54. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease. Ann N Y Acad Sci. 2008 Dec; 1147:206-20. Henchcliffe C, Shungu DC, Mao X, Huang C, Nirenberg MJ, Jenkins BG, Beal MF. PMID: 19076443.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    55. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008 Nov; 4(11):600-9. Henchcliffe C, Beal MF. PMID: 18978800.
      View in: PubMed   Mentions: 323     Fields:    Translation:HumansAnimalsCells
    56. Cancer and blood concentrations of the comutagen harmane in essential tremor. Mov Disord. 2008 Sep 15; 23(12):1747-51. Louis ED, Pellegrino KM, Factor-Litvak P, Rios E, Jiang W, Henchcliffe C, Zheng W. PMID: 18709680; PMCID: PMC2597456.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    57. Rasagiline in treatment of Parkinson's disease. Neuropsychiatr Dis Treat. 2008 Feb; 4(1):23-32. Nayak L, Henchcliffe C. PMID: 18728823; PMCID: PMC2515917.
      View in: PubMed   Mentions: 13  
    58. Case study of an unusual variant of restless leg syndrome. Mov Disord. 2008 Jan; 23(1):153. Ebben MR, Pollak CP, Henchcliffe C. PMID: 17992696.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology. 2008 Mar; 29(2):294-300. Louis ED, Jiang W, Pellegrino KM, Rios E, Factor-Litvak P, Henchcliffe C, Zheng W. PMID: 18242711; PMCID: PMC2291546.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    60. Young-onset Parkinson's disease: hospital utilization and medical comorbidity in a nationwide survey. Neuroepidemiology. 2007; 29(1-2):39-43. Louis ED, Henchcliffe C, Bateman BT, Schumacher C. PMID: 17898522.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    61. Retraction. Young-onset Parkinson's disease: hospital utilization and medical comorbidity in a nationwide survey. Mov Disord. 2007 Mar 15; 22(4):450. Louis ED, Henchcliffe C, Bateman BT, Schumacher HC. PMID: 17390387.
      View in: PubMed   Mentions:    Fields:    
    62. Excitotoxicity. Handb Clin Neurol. 2007; 83:553-69. Henchcliffe C, Beal MF. PMID: 18808934.
      View in: PubMed   Mentions:    Fields:    
    63. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci U S A. 2006 Dec 05; 103(49):18757-62. Ries V, Henchcliffe C, Kareva T, Rzhetskaya M, Bland R, During MJ, Kholodilov N, Burke RE. PMID: 17116866; PMCID: PMC1654135.
      View in: PubMed   Mentions: 72     Fields:    Translation:AnimalsCells
    64. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors. Expert Rev Neurother. 2005 Nov; 5(6):811-21. Henchcliffe C, Schumacher HC, Burgut FT. PMID: 16274338.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    65. Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system. J Neurol Neurosurg Psychiatry. 2005 Apr; 76(4):540-4. Baehring JM, Henchcliffe C, Ledezma CJ, Fulbright R, Hochberg FH. PMID: 15774442; PMCID: PMC1739607.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    66. Entacapone in the management of Parkinson's disease. Expert Opin Pharmacother. 2002 Jul; 3(7):957-63. Henchcliffe C, Waters C. PMID: 12083995.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J Neurochem. 1999 Feb; 72(2):557-64. Oo TF, Henchcliffe C, James D, Burke RE. PMID: 9930727.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    68. Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra. Neurosci Lett. 1997 Jul 11; 230(1):41-4. Henchcliffe C, Burke RE. PMID: 9259459.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    69. Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J Neurosci. 1996 Oct 01; 16(19):6134-45. Oo TF, Blazeski R, Harrison SM, Henchcliffe C, Mason CA, Roffler-Tarlov SK, Burke RE. PMID: 8815896; PMCID: PMC6579170.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    70. Apoptosis in substantia nigra following developmental hypoxic-ischemic injury. Neuroscience. 1995 Dec; 69(3):893-901. Oo TF, Henchcliffe C, Burke RE. PMID: 8596657.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    71. Genetic analysis of laminin A reveals diverse functions during morphogenesis in Drosophila. Development. 1993 Jun; 118(2):325-37. Henchcliffe C, García-Alonso L, Tang J, Goodman CS. PMID: 8223265.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    72. Cell type specific trans-acting factors are involved in alternative splicing of human fibronectin pre-mRNA. EMBO J. 1989 Apr; 8(4):1079-85. Barone MV, Henchcliffe C, Baralle FE, Paolella G. PMID: 2545440; PMCID: PMC400917.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    73. Sequence analysis and in vivo expression show that alternative splicing of ED-B and ED-A regions of the human fibronectin gene are independent events. Nucleic Acids Res. 1988 Apr 25; 16(8):3545-57. Paolella G, Henchcliffe C, Sebastio G, Baralle FE. PMID: 3375063; PMCID: PMC336511.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Claire's Networks
    Concepts (284)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California